Abiopharma

CALUMET, INC. /DE (CLMT)

Symbol	CLMT
Name	CALUMET, INC. /DE
Sector	ENERGY
Region	North America
Industry	Petroleum Refining
Address	1060 N CAPITOL AVE, INDIANAPOLIS, IN 46204
Telephone	(317) 328-5660
Fax	—
Email	—
Website	https://www.calumet.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0002013745
Description	Calumet Specialty Products Partners LP is an independent producer of specialty hydrocarbon products in North America. The company operates through three segments namely Specialty Products and Solutions segment manufacture and market solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. In Performance Brands segment, the company blend, package and market high performance products through its Royal Purple, Bel-Ray, and TruFuel brands. The Montana/Renewables segment is comprised of two businesses - renewable diesel and specialty asphalt. The Corporate segment primarily consists of general and administrative expenses not allocated to the Specialty Products and Solutions, Performance Brands or Montana/Renewables segments. Additional info from NASDAQ: Calumet Specialty Products Partners LP is an independent producer of specialty hydrocarbon products in North America. The company operates through three segments namely Specialty Products and Solutions segment manufacture and market solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. In Performance Brands segment, the company blend, package and market high performance products through its Royal Purple, Bel-Ray, and TruFuel brands. The Montana/Renewables segment is comprised of two businesses - renewable diesel and specialty asphalt. The Corporate segment primarily consists of general and administrative expenses not allocated to the Specialty Products and Solutions, Performance Brands or Montana/Renewables segments.

2026-04-23 11:00

Calumet, Inc. to Release First Quarter 2026 Earnings on May 8, 2026

2026-04-20 17:06

New Form ARS - Calumet, Inc. /DE Filed: 2026-04-20 AccNo: 0001140361-26-015647 Size: 8 MB

2026-04-20 17:03

New Form DEFA14A - Calumet, Inc. /DE Filed: 2026-04-20 AccNo: 0001140361-26-015642 Size: 994 KB

2026-04-06 11:48

Calumet Announces Intention to Nominate Bradford T. Sanders to Board of Directors

2026-04-02 20:19

Sajkowski Daniel J 🔴 sold 3.3K shares of Calumet, Inc. /DE (CLMT) at $34.46 Transaction Date: Apr 01, 2026 | Filing ID: 000005

2026-04-02 20:16

Morical Gregory J 🟢 acquired 1.3K shares (2 derivative) of Calumet, Inc. /DE (CLMT) Transaction Date: Mar 31, 2026 | Filing ID: 000003

2026-04-02 20:14

Fleming Bruce A 🟢 acquired 17.4K shares (2 derivative) of Calumet, Inc. /DE (CLMT) Transaction Date: Mar 31, 2026 | Filing ID: 000003

2026-04-02 20:13

Borgmann Louis Todd 🟢 acquired 9.6K shares (2 derivative) of Calumet, Inc. /DE (CLMT) Transaction Date: Mar 31, 2026 | Filing ID: 000003

2026-04-02 20:11

Krutz John Robert 🟢 acquired 1.2K shares (2 derivative) of Calumet, Inc. /DE (CLMT) Transaction Date: Mar 31, 2026 | Filing ID: 000002

2026-04-02 12:51

New Form SCHEDULE 13G/A - Calumet, Inc. /DE Filed: 2026-04-02 AccNo: 0001386929-26-000002 Size: 6 KB